Go to content
News Releases

Nano One Core Patents Receive US Notice Of Allowance

Share this article:

Vancouver, B.C. June 29, 2015: Nano One Materials Corp. (“Nano One” or the “Company”) (TSX Venture: NNO) wishes to announce that the U.S. Patent and Trademark Office (“USPTO”) recently issued a notice of allowance on two of the Company’s patent applications.

The notice represents an important success on the Company’s intellectual property protection activities. These applications are related to the proprietary method of making powders for specialized applications and the method for making lithium metal oxide powders for battery applications. The USPTO issues a notice of allowance after it makes a determination that a patent should be granted from a patent application. Issuance is expected in late 2015.

“There are additional applications pending around the world, that are related to specific high-performance advanced materials being formed by the proprietary methods” stated Dr. Joseph Guy, Patent Agent and Director, “and favorable review of the patent applications validates the novelty of the technology and positions Nano One as a viable player in the advanced lithium ion cathode material sector”.

Dr. Byron Gates, Associate Professor at Simon Fraser University and advisor to the Company, added “Nano One is a pioneer in advanced material synthesis for applications that include lithium ion cathodes that could increase cycling, charging and capacity. Nano One’s synthesis of lithium ion materials is simple and efficient, and it`s methodology is also flexible enough to prepare a wide variety of nanomaterials. The analytical results are promising and I’m excited about the possibilities”.

About Nano One

Nano One Materials Corp is focused on developing novel, scalable and low-cost processing technology for the production of high performance battery materials. The technology can be configured for a wide range of raw materials with the flexibility to shift with market trends and growth opportunities in other advanced nanostructured composite materials. The novel three-stage process uses equipment common to industry and is being engineered for high volume production and rapid commercialization. Nano One’s mission is to establish its patent pending technology as a leading platform for the global production of a new generation of nanostructured composite materials.

About Dr. Joseph Guy

Dr. Joseph Guy is Nano One’s patent agent and serves on Nano One’s board of directors. He is a Patent Agent with Perkins Law Firm’s Intellectual Property group focusing on complex technologies including material science, electronic components, pharmaceuticals and medical products. He has more than 23 years of experience prosecuting patents and serving as expert witness on intellectual property matters. Dr. Guy was awarded a Ph.D. in Chemistry from the University of Wisconsin-Milwaukee in physical inorganic chemistry with a focus on organometallic complexes. After a post-doctoral fellowship at Naval Research Laboratories, Dr. Guy joined E.I. duPont de Nemours & Co. in Brevard, North Carolina where he conducted research in medical imaging technologies.

Dr. Guy later transitioned to intellectual property manager where his primary responsibility was management of the Intellectual Property portfolio and license negotiations for the Medical Products Division. The Medical Products Division was divested to Sterling Diagnostic Imaging, Inc. in 1996 and Dr. Guy was appointed corporate patent manager responsible for managing the intellectual property for a multinational corporation. Dr. Guy has authored numerous references in peer-reviewed journals and has written and prosecuted over 1000 U.S. and foreign patent applications, with more than 400 issued U.S. Patents and numerous foreign patents. His corporate research, management experience and intellectual property backgrounds merge to provide excellent experience in the development of an IP portfolio tailored to augment corporate strategies.

About Dr. Byron Gates

Dr. Byron Gates is Nano One’s Chemistry and Nanomaterial Advisor; he advises the Company on physical and analytical chemistry, laboratory facilities and team building. Dr. Gates is a Tier II Canada Research Chair in the Department Chemistry at Simon Fraser University, investigating the surface and interface chemistry of nanomaterials and is the Head of the Centre for Soft Materials in 4D LABS, a materials research institute at SFU. Dr. Gates received his Ph.D. from the University of Washington with Professor Younan Xia, and was a postdoctoral fellow at Harvard University working with Professor George M. Whitesides. (www.sfu.ca/chemistry/groups/gates)

Dr. Gates’ work includes a series of analytical and materials studies to prepare and analyze the surface chemistries of nanostructured materials. Dr. Gates has also demonstrated new technologies in materials design and fabrication through self-assembly and patterning. These technologies are being applied across many scientific disciplines and in new areas of research that include the study ofcatalyst layers and catalyst supports in low temperature fuel cells, corrosion in nanoscale materials, detection and workplace remediation of nanomaterials, and development of both enhanced, high-resolution biological imaging and on-demand delivery and release of therapeutics for use in the management of cancer.



Dan Blondal, CEO 

For information with respect to Nano One or the contents of this news release, please contact Ryan Johnson (Corporate Development) or John Lando (President) at (604) 669-2701 or visit the website at www.nanoone.ca.

Certain information contained herein may constitute “forward-looking information” under Canadian securities legislation. Forward-looking information includes, but is not limited to, statements with respect to the commercialization of the Company’s technology and patents. Generally, forward-looking information can be identified by the use of forward-looking terminology such as “expects” or “it is expected”, or variations of such words and phrases or statements that certain actions, events or results “will” occur. Forward-looking statements are based on the opinions and estimates of management as of the date such statements are made and they are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements or forward-looking information, including: the receipt of all necessary regulatory approvals. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. The Company does not undertake to update any forward-looking statements or forward-looking information that is incorporated by reference herein, except as required by applicable securities laws.



Related Posts

See All

Related Posts

See All